Navigation Links
Colorectal cancer screening in Canada is cost-effective
Date:7/12/2010

Colorectal cancer screening is cost-effective and offers the best value for provincial health ministries in Canada, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj090845.pdf. A high sensitivity fecal test, such as the fecal immunochemical test, or colonoscopy every ten years is recommended.

Increased advanced detection helps prevent cancer and avoids future treatment costs.

The study, by researchers from the University of British Columbia and Dalhousie University, analyzed 10 screening strategies (including no screening) recommended in the American 2008 Multi-Society Task Force Guidelines on colorectal cancer screening.

"Depending on the strategy, screening yields reductions in colorectal cancer mortality between 39% and 83% and incidence between 26% and 81%," write Dr. Jennifer Telford and Dr. Robert Enns, University of British Columbia with coauthors.

These findings are consistent with previously published studies.

"Colorectal cancer screening of average-risk individuals is a cost-effective measure, even with less than perfect compliance," conclude the authors.


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Page: 1

Related medicine news :

1. Could Hot Weather Affect Results of a Colorectal Cancer Test?
2. Smoking-related colorectal cancer in older women is associated with molecularly defined DNA changes
3. Smoking-related colorectal cancer in older women is associated with molecularly-defined DNA changes
4. Hydrophobic proteins: Potential biomarkers for colorectal cancer
5. Is it safe for endoscopic piecemeal mucosal resection in treating large sessile colorectal polyps?
6. Bacteria as a predicter of colorectal cancer
7. Exploring gender differences in colorectal cancer screenings
8. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
9. Investigators examine colorectal cancer screening methods among diverse populations
10. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
11. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... SALT LAKE CITY, UTAH (PRWEB) , ... April ... ... Josée Côté as Account Manager for the North East region. Côté has 20+ ... operations and consulting. Prior to Phytomer, Côté worked with an array of high-end ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that has ... presence to an educational purpose as the host of the “Informed” series. The program ... a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis of ... field. Offering practical takeaways to apply immediately to IRR programs, the report highlights ...
(Date:4/27/2017)... Neb. (PRWEB) , ... April 27, 2017 , ... ... was named the 2017 North American CAREGiverSM of the Year for her extraordinary ... selects one of its 60,000 North American professional caregivers for the prestigious award ...
(Date:4/27/2017)... GA (PRWEB) , ... April 27, 2017 , ... Are ... a tragic spike in water-related accidents and drownings during the summer. While most of ... is that these situations occur every day. Very few people are taking the time ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology: